Transmyocardial laser revascularization in the treatment of end-stage coronary artery disease

T Krabatsch1, L Tambeur, E Lieback

  • 1Department of Cardio-thoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.

Insights

Transmyocardial laser revascularization (TMR) provided angina relief and improved endurance in severe angina patients. While not improving myocardial function, TMR showed reduced mortality and justified its use in select cases.

Area of Science:

  • Cardiology
  • Minimally Invasive Surgery

Background:

  • Severe angina pectoris often presents in patients unresponsive to medical therapy.
  • Conventional treatments like bypass surgery or PTCA may not be suitable for all severe angina patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of Transmyocardial laser revascularization (TMR) in patients with severe angina pectoris.
  • To assess TMR's impact on angina symptoms, physical endurance, myocardial perfusion, and left ventricular contractility.

Main Methods:

  • Transmyocardial laser revascularization (TMR) was performed on 171 patients between July 1994 and December 1997.
  • Patients included those for whom conventional bypass surgery or PTCA were not viable options.

Main Results:

  • A significant decrease in angina symptoms and improved physical endurance were observed in most patients post-TMR.
  • No statistically significant increase in myocardial perfusion or left ventricular contractility was detected.
  • Perioperative mortality decreased from 8% to 2.5% over the study period, with an overall mortality of 7%.

Conclusions:

  • TMR appears to justify its use for symptom relief and improved quality of life in carefully selected patients with severe angina.
  • Further research is needed to conclusively assess the long-term effects and definitive role of TMR due to its experimental nature.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...